Glivec in Ph Positive Lymphoblastic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2007

Conditions
Acute Lymphoblastic LeukemiaCromosome Philadelphia Positive
Interventions
DRUG

chemotherapy

DRUG

Glivec

Trial Locations (28)

Unknown

Hospital General de Alicante, Alicante

"Hospital Duran I Reynals", Barcelona

"Hospital Santa Creu i Sant Pau", Barcelona

Hospital Clínico y Provincial de Barcelona, Barcelona

Hospital del Mar, Barcelona

Hospital Germans Trias i Pujol, Barcelona

"Hospital Universitario Germans Trias i Pujol", Barcelona

Hospital Valle Hebrón-Materno Infantil, Barcelona

Hospital Valle Hebrón, Barcelona

Hospital Universitario Marqués de Valdecilla, Santander

Hospital Puerta del Mar, Cadiz

Hospital Juan Canalejo, A Coruña

Fundación Jiménez Díaz, Madrid

Hospital Clínico San Carlos de Madrid, Madrid

Hospital Doce de Octubre, Madrid

Hospital Gregorio Marañón, Madrid

Hospital Ramón y Cajal, Madrid

Hospital General Universitario Morales Meseguer., Murcia

. Hospital Clínico Universitario Virgen de la Victoria, Málaga

Hospital Carlos Haya, Málaga

Clínica Universitaria de Navarra, Pamplona

Hospital Central de Asturias, Oviedo

Hospital Son Dureta, Palma de Mallorca

Hospital Son Llàtzer, Palma de Mallorca

Hospital Universitario Virgen del Rocío, Seville

Hospital Clínico de Valencia, Valencia

Hospital La Fe, Valencia

Hospital Clínico Universitario de Salamanca, Salamanca

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00388895 - Glivec in Ph Positive Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter